Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1613-1617

  Poirel, Laurent ^a,b   Mansour, Wejdene ^a,b,c   Bouallegue, Olfa ^c   Nordmann, Patrice ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CARBAPENEM;

ACINETOBACTER BAUMANNII; AFRICA; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CHROMOSOME ANALYSIS; GENE IDENTIFICATION; GENE SEQUENCE; GENE STRUCTURE; HOSPITAL INFECTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; TUNISIA;

ACINETOBACTER BAUMANNII; AFRICA; BACTERIAL PROTEINS; BETA-LACTAMASES; BLOTTING, SOUTHERN; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TUNISIA;

EID: 42949110580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00978-07     Document Type: Article

References (32)

1. Bertini, A., A. Giordano, P. Varesi, L. Villa, C. Mancini, and A. Carattoli. 2006. First report of the plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob. Agents Chemother. 50:2268-2269.
2. OXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:2324-2328.
3. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Coelho, J., N. Woodford, M. Afzal-Shah, and D. M. Livermore. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50:756-758.
5. Corbella, X., A. Montero, M. Pujol, M. A. Domínguez, J. Ayats, M. J. Argerich, F. Garrigosa, J. Ariza, and F. Gudiol. 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol. 38:4086-4095.
6. OXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533.
7. Dortet, L., P. Legrand, C. J. Soussy, and V. Cattoir. 2006. Bacterial identification, clinical significance, and antimicrobial susceptibility of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J. Clin. Microbiol. 44:4471-4478.
8. Giordano, A., P. Varesi, A. Bertini, L. Villa, A. M. Dionisi, M. Venditti, P. Carfagna, I. Luzzi, C. Mancini, and A. Carattoli. 2007. Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy. Microb. Drug Resist. 13:37-43.
9. Hanlon, G. W. 2005. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett. Appl. Microbiol. 41:375-378.
10. Héritier, C., A. Dubouix, L. Poirel, N. Marty, and P. Nordmann. 2005. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolyzing oxacillinase OXA-58. J. Antimicrob. Chemother. 55: 115-118.
11. Héritier, C., L. Poirel, and P. Nordmann. 2006. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123-130.
12. Héritier, C., L. Poirel, P. E. Fournier, J. M. Claverie, D. Raoult, and P. Nordmann. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179.
13. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
14. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.
15. Liu, S. L., A. Hessel, and K. E. Sanderson. 1993. Genomic mapping with I-CeuI, an intron-encoded endonuclease specific for genes for ribosomal RNA. in Salmonella spp., Escherichia coli, and other bacteria. Proc. Natl. Acad. Sci. USA 90:6874-6878.
16. Navon-Venezia, S., R. Ben-Ami, and Y. Carmeli. 2005. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18:306-313.
17. Paterson, D. L. 2006. The epidemiological profile of infections with multi-drug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis. 43(Suppl. 2):S43-S48.
18. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
19. Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.
20. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769-776.
21. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
22. OXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50: 1442-1448.
23. Poirel, L., E. Lebessi, C. Héritier, A. Patsoura, M. Foustoukou, and P. Nordmann. 2006. Nosocomial spread of OXA-58-positive carbapenem-re-sistant Acinetobacter baumannii isolates in a pediatric hospital in Greece. Clin. Microbiol. Infect. 12:1138-1141.
24. Poirel, L., S. Marqué, C. Héritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208.
25. Pournaras, S., A. Markogiannakis, A. Ikonomidis, L. Kondyli, K. Bethimouti, A. N. Maniatis, N. J. Legakis, and A. Tsakris. 2006. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J. Antimicrob. Chemother. 57:557-561.
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Schlüter, A., R. Szczepanowski, N. Kurz, S. Schneiker, I. Krahn, and A. Pühler. 2007. Erythromycin resistance-conferring plasmid pRSB105, isolated from a sewage treatment plant, harbors a new macrolide resistance determinant, an integron-containing Tn402-like element, and a large region of unknown function. Appl. Environ. Microbiol. 73:1952-1960.
28. Segal, H., S. Garny, and B. G. Elisha. 2005. Is ISAba1 customized for Acinetobacter? FEMS Microbiol. Lett. 243:425-429.
29. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
30. Turton, J. F., M. E. Ward, N. Woodford, M. E. Kaufmann, R. Pike, D. M. Livermore, and T. L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
31. Walsh, T. R., A. Holmström. A. Qwärnström, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-β- lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.
32. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.